PharmiWeb.com - Global Pharma News & Resources

Company Directory - Research & Development

AI & Medicine has proudly developed a unique artificial intelligence drug research and development platform to offer drug development solutions for worldwide customers from the medical institutions and pharmaceutical enterprises.
The purpose of Agilent Research Laboratories is to power Agilent’s growth through breakthrough science and technology.
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across, and beyond, the drug development lifecycle to the pharmaceutical and biotech sectors globally.
Almirall is a leading skin-health focused global pharmaceutical company that partners with healthcare professionals, applying science to provide medical solutions to patients and future generations. Our efforts are focused on fighting skin health diseases and helping people feel better.
Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer.
Bavarian Nordic is a fully integrated biotechnology company focused on the development of innovative therapies against infectious diseases and cancer.
Bioniz Therapeutics is a clinical-stage biopharmaceutical company leading the discovery and development of first-in-class multi-cytokine inhibitory peptide therapeutics to address immuno-inflammatory diseases and cancer.
The clinical development of drugs and devices is crucial for human welfare. Our mission is to improve success rates in this endeavor. We do this by improving the design and implementation of clinical trials through the innovative application of stat
Eon Market Research (EMR) is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-make
We revolutionize the way of cancer diagnostics using our unique, proprietary DNA methylation biomarker technology. Epigenomics develops and commercializes patient-friendly, blood-based diagnostic tests across multiple cancer indications with high medical need.
We specialise in high-growth niche markets, assuring flexibility, agility and customized solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront.
We deliver the understanding of the genomic drivers of every disease for Pharma. Our curated Genomic Landscapes provide immediate insight into the genomic evidence for every phenotype, disease, gene, and variant.